RLAY Earnings

Quarterly EPS
$-0.45
Q4 2024
$-0.46
Q1 2025
$-0.41
Q2 2025
$-0.43
Q3 2025
$-0.32
Q4 2025
$-0.41
Q1 2026
$-0.41
Q2 2026
$-0.37
Q3 2026
Latest RevenueN/A
Latest Net Income-81745000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.370-81745000—+14.0%
Q2 2026-$0.41350.0K-83707000-48.3%+0.0%
Q1 2026-$0.413.0M-73291000-60.9%+10.9%
Q4 2025-$0.327.0M-54890000—+28.9%
Q3 2025-$0.430-74149000—+31.7%
Q2 2025-$0.41677.0K-70375000—+40.6%
Q1 2025-$0.467.7M-77065000-23.3%+25.8%
Q4 2024-$0.450-76004000——
Q3 2024-$0.630-88105000——
Q2 2024-$0.690-92212000——
Q1 2024-$0.6210.0M-81387000——
Q4 2023—————
Relay Therapeutics (RLAY) — Earnings